Zemuron and Paralysis - a phase IV clinical study of FDA data
Summary:
Paralysis is reported as a side effect among people who take Zemuron (rocuronium bromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Bridion, and have Neuromuscular blockade reversal.
The phase IV clinical study analyzes which people have Paralysis when taking Zemuron. It is created by eHealthMe based on reports of 872 people who have side effects when taking Zemuron from the FDA, and is updated regularly.
What is Zemuron?
Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.
What is Paralysis?
Paralysis is found to be associated with 1,894 drugs and 1,511 conditions by eHealthMe. Check the latest studies of Paralysis.
872 people reported to have side effects when taking Zemuron.
Among them, 19 people (2.18%) have Paralysis.
Among these 19 people:
How long have people been on Zemuron when they have Paralysis? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Paralysis when taking Zemuron? *
- female: 80 %
- male: 20 %
What is the age of people who have Paralysis when taking Zemuron? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 21.43 %
- 20-29: 7.14 %
- 30-39: 28.57 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 42.86 %
What are other drugs people take besides Zemuron? *
- Bridion: 4 people, 21.05%
- Propofol: 3 people, 15.79%
- Sevoflurane: 3 people, 15.79%
- Insulin: 3 people, 15.79%
- Dilaudid: 3 people, 15.79%
- Versed: 3 people, 15.79%
- Cancidas: 3 people, 15.79%
- Demerol: 2 people, 10.53%
- Prevacid: 2 people, 10.53%
- Fentanyl: 2 people, 10.53%
What are other side effects people have besides Paralysis? *
- Apnea (temporary absence or cessation of breathing): 4 people, 21.05%
- Respiratory Arrest (Excl Neonatal) (cessation of normal respiration due to failure of the lungs to function effectively (excluding neonatal)): 3 people, 15.79%
- Anaesthetic Complication Neurological: 2 people, 10.53%
- Unresponsive To Stimuli: 1 person, 5.26%
- Recurrence Of Neuromuscular Blockade (repeat neuromuscular block): 1 person, 5.26%
- Overdose: 1 person, 5.26%
- Neuromuscular Block Prolonged: 1 person, 5.26%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 5.26%
- Hearing Loss: 1 person, 5.26%
- Drug Effect Prolonged: 1 person, 5.26%
What are the existing conditions these people have? *
- Neuromuscular Blockade Reversal: 3 people, 15.79%
- Hypotonia (low muscle tone): 2 people, 10.53%
- Neuromuscular Blockade: 1 person, 5.26%
- Nausea And Vomiting: 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Zemuron and have Paralysis?
- Check whether Paralysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zemuron:
- Zemuron (873 reports)
Paralysis treatments and more:
- Paralysis (17,723 reports)
How severe was Paralysis and when was it recovered:
Expand to all the drugs that have ingredients of rocuronium bromide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zemuron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Paralysis:
- Paralysis (1,894 drugs)
Browse all the conditions that are associated with Paralysis:
- Paralysis (1,511 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rocuronium bromide (the active ingredients of Zemuron) and Zemuron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.